Global Bioinformatics Services Market Size, Share & Trends Analysis Report by Type (NGS, Chemoinformatic), by Application (Genomics, Transcriptomics, Proteomics, Metabolomics, Drug Discovery, Others), by Sector (Medical, Animal, Agricultural, Academics) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast (2025–2034). The report offers the value (in USD Billion) for the above segments.

Market Overview

The Bioinformatics Services Market size was valued at around 3.20 billion in 2024 and is expected to reach a value of USD 12.39 billion by 2034, at a CAGR of 14.5% over the forecast period (2025–2034).

Bioinformatics services are extensively used by biotech and pharmaceutical industries for quickening drug discovery and development processes. Such tools aid in uncovering disease mechanisms, discovery of potential drug targets, and prediction of drug interactions. Integrating bioinformatics in drug development is now a crucial strategy for companies looking to lower costs and timelines associated with bringing new therapies to market. As biologics and biosimilars grow, the demand for bioinformatics solutions is likely to rise.
Cloud computing provides scalable, adaptable, and affordable platforms for data storage and analysis of big data, enabling advanced bioinformatics tools to be accessible to organizations of all sizes. This movement towards cloud services is especially beneficial for small businesses and research teams that lack the means for costly infrastructure. In addition, the ability to work together globally and exchange data in real time is also propelling the adoption of cloud-based bioinformatics solutions across industries.

The bioinformatics services market is witnessing a wave of strategic alliances and partnerships driven by the pressure to leverage abilities of the service and move into new markets. Leading bioinformatics players are joining hands with pharma, academia, and IT companies to bring together talent and meet growing demand for high-performance data analysis software. The partnerships have an agenda of integrating bioinformatics with cloud computing, designing new algorithms to analyse data, and co-creating personalized medicine solutions.

Market Drivers

Growing Applications of Bioinformatics in Various Industries

• Bioinformatics services are also being exploited by several industries, such as the food, bioremediation, Agri, forensic, and consumer industries, to add value to their supply chain activities and products. Companies across a range of industries are increasingly making use of bioinformatics services, such as data integration, manipulation, lead identification, data administration, in silico analysis, and advanced knowledge discovery. It is expected that the growth of bioinformatics service application fields would create new revenue opportunities for market players, thereby stimulating the adoption of these services and driving the market overall.

Increasing Public-Private Sector Funding for Bioinformatics Services

• More public-private sector investments are a major force behind the growth of bioinformatics services. Life sciences research, especially genomics, precision medicine, and drug discovery, heavily depend on bioinformatics software and services, and governments and private entities are seriously investing in such areas. The investments are to speed up scientific advances, enhance the quality of healthcare, and create targeted therapies. Public investments tend to fund large-scale research projects, infrastructure construction, and academic studies, while private investments target product development and commercialization. National genomics initiatives and pharmaceutical R&D initiatives increasingly rely on bioinformatics to handle complex biological information. Not only does this financing boost the ability for innovation but also raise demand for specialized bioinformatics knowledge and infrastructure, thus stimulating market growth. Therefore, bioinformatics service providers are in a better position to create sophisticated analytical tools, improve data integration ability, and provide customized solutions to various applications in life sciences.

Market Opportunities

Reducing Cost of Sequencing and Growing Volume of Data Generated During Sequencing

• The price of genome sequencing has come down quite a bit over the last 20 years, primarily due to technological advances in this field. World-wide acceptance of the latest sequencing technologies has been strongly driven by the low price of advanced, accurate, and high-throughput systems as well as the reduced cost of sequencing.

Growth Potential in Emerging Economies

• Emerging economies have tremendous growth potential for the market of bioinformatics services with an increasing healthcare infrastructure, increasing research activity, and increasing use of advanced technologies. India, China, Brazil, and South Africa are experiencing an explosion in research in genomics, clinical diagnostics, and pharma development that is fuelling demand for bioinformatics tools as well as professionals. In addition, favourable government policies, emergence of biotech start-up clusters, and partnerships with international institutions are driving investments in life sciences and data-driven healthcare. The regions have cost advantages in outsourcing bioinformatics services and are thus an attractive destination for international service providers. As the movement towards precision healthcare and personalized medicine gains momentum, so does the need for data interpretation and analysis capability. The relatively unexploited nature of these markets combined with the increasing pool of competent professionals and increased digitalization renders emerging economies key to future development in the global bioinformatics services market.

Market Restraining Factors

In-House Development of Bioinformatics Solutions and Publicly Available Bioinformatics Tools

• Most biomedical labs, biotech firms, and pharmaceutical firms are creating their own bioinformatics capabilities due to the growing demand for constant feedback from bioinformatics professionals. The development of bioinformatics solutions in-house enables firms to customize the applications of the tools to the needs of their research project. Apart from drug development companies, many research institutions are developing sophisticated bioinformatics ideas and freely available bioinformatics tools. Though growth in the bioinformatics services market is being retarded, the arrival of open-source bioinformatics software and freely downloadable data/software is supporting the development of the overall bioinformatics market.

Segmentation Analysis

The market scope is segmented because of by Type, by Application, by Sector.

• By Type

Based on the Type of the market is segmented into NGS, Chemoinformatic.

Among the many bioinformatics services offered in the market, the Next-Generation Sequencing (NGS) sector has dominated the market. This is because of the extensive application and growing applications of NGS technologies in genomics, transcriptomics, and epigenetics research. NGS provides enormous amounts of data within a relatively short time and at low cost compared to conventional sequencing techniques, hence gaining popularity among researchers and clinicians. The increasing focus on personalized medicine based on genome-dependent diagnostics and therapy planning continues to drive demand for NGS-based bioinformatics support. Clinically, NGS is increasingly deployed for cancer genomics, diagnosing rare disease, and diagnosing infectious diseases, all three of which call for advanced analysis and interpretation of complex data that necessitates advanced bioinformatics input.

Sequencing platform advancements, coupled with improved computational software and algorithms, enabled seamless integration and analysis of NGS data. The strong research pipeline of study projects that leverage NGS in academic, pharmaceutical, and biotechnology sectors sustains the growth segment. By contrast, though cheminformatics also has an important role to play especially in drug discovery and molecular modelling, it cannot be matched with the widespread applicability and intense technological progress involved with NGS. Accordingly, the NGS segment remains dominant in the bioinformatics services market driven by growing applications and relentless innovation in sequencing and data processing technologies.

• By Application

Based on the Application of the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics, Drug Discovery, Others.

Among the application of the market for bioinformatics services, genomics is at present the dominant segment. This is primarily because of the rapid growth and mass usage of genome sequencing technologies, particularly for research and clinical diagnostics. Genomics involves the examination and interpretation of an entire DNA sequence of a species, and bioinformatics services occupy a central place in the management, processing, and analysis of the enormous dataset that high-throughput sequencing technologies such as Next-Generation Sequencing (NGS) produce. Increased use of genomics in personalized medicine, genetic disease research, oncology, and evolutionary studies has created sustained demand for bioinformatics services.

Government-funded initiatives such as national genome projects and precision medicine initiatives have also accelerated the growth of genomics-related services by stimulating alliances among hospitals, academic institutions, and for-profit entities. Declining costs of sequencing and advancements in data analysis software have also increased opportunities for genomic research for more users such as smaller research facilities and clinical laboratories. As compared to the other areas like transcriptomics, proteomics, and metabolomics that are also gaining much popularity genomics is the most developed and used field. While drug discovery is another significant problem, it too is largely based on knowledge that has been generated with the use of results from genomic research further establishing the place of genomics in the bioinformatics service economy. Thus, the dominance of the genomics segment is supported both in terms of technology progress as well as by virtue of its underlying applicability to a plethora of domains in life sciences and healthcare.

• Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America has long dominated the world bioinformatics services market, spearheaded by its mature biotech and pharma industries, in addition to strong genomics and precision medicine investments. The region boasts a well-established research environment, backed by strong public and private sector research funding for the life sciences. Institutions and organizations in the U.S. and Canada have always been at the forefront of developing and using state-of-the-art bioinformatics tools, due to the presence of high-end infrastructure, trained personnel, and a positive regulatory environment. The leadership position of the region in the market has also been fuelled by early adoption of next-generation sequencing technologies and the presence of large commercial and academic research institutions.

On the other hand, the Asia-Pacific region is expected to be the fastest-growing market in the forecast period. The growth is driven by increased investment in biotechnology and healthcare, increased awareness of personalized medicine, and increased emphasis on genomics research. India and China are quickly building their bioinformatics prowess through government programs, training programs, and partnerships with overseas research centres. The availability of a huge pool of highly qualified professionals at competitive rates also makes the region attractive for outsourcing bioinformatics services. With ongoing expansion of digital health technologies and genomics programs, the Asia-Pacific region will likely have an increasing global share in the bioinformatics services market.

List of Companies Profiled

• Agilent Technologies, Inc.
• BGI Group
• Dotmatics
• Labvantage - Biomax GmbH
• CD Genomics
• Creative Biolabs
• DNAnexus, Inc
• DNASTAR
• Fios Genomics
• Illumina, Inc.
• PerkinElmer Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.

Key Industry Developments

In July 2023, FOXO Technologies debuted its Bioinformatics Services, which will revolutionize the analysis of epigenetic data. The platform speeds up breakthroughs in biology, biotechnology, and healthcare and redefines the expanding field of epigenetic research. This endeavour solves the long-standing issues in processing, analyzing, and interpreting epigenetic data.

In May 2023, CD Genomics, a top genomics and bioinformatics solutions provider, launched its long-read metagenomics sequencing service in the United States.

In March 2022, the Australian government provided AUD 28.1 million (USD 21.1 million) to fund the creation of Genomics Australia, an agency with a mandate to promote the implementation of genomic medicine in the healthcare system of the country.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Bioinformatics Services Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Bioinformatics Services Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Bioinformatics Services market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Bioinformatics Services. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Bioinformatics Services companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Bioinformatics Services Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Bioinformatics Services Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Bioinformatics Services Market valued?
• Which region has the largest share in 2025 for the global Bioinformatics Services Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Bioinformatics Services Market

• Historic year: 2020-2023
• Base year: 2024
• Forecast: 2025 to 2034
• Representation of Market revenue in USD Billion

Bioinformatics Services Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: